Joshua Reed
Förmögenhet: 787 615 $ per 2026-10-31
Förmögenhet: 787 615 $ per 2026-10-31
Mr. Joshua Reed is a Chief Financial Officer & Senior Vice President at Alkermes Plc and an Independent Director at Scholar Rock Holding Corp.
He is on the Board of Directors at Scholar Rock Holding Corp.
Mr. Reed was previously employed as a Chief Financial & Accounting Officer by Omega Therapeutics, Inc., a Chief Financial Officer & Treasurer by Aldeyra Therapeutics, Inc., a Vice President & Head-Finance Operations by Bristol Myers Squibb Co., and a Vice President-Strategic Business Development by JPMorgan Chase & Co. He received his undergraduate degree from Rutgers State University of New Jersey and an MBA from Stephen M.
Ross School of Business.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-01 | 12 679 ( 0,01 % ) | 556 608 $ | 2026-10-31 | |
| 2026-10-08 | 5 095 ( 0 % ) | 231 007 $ | 2026-10-31 |
| Företag | Position | Start |
|---|---|---|
| ALKERMES PLC | Finansdirektör/CFO | 2025-09-15 |
| SCHOLAR ROCK HOLDING CORPORATION | Direktör/Styrelseledamot | 2021-03-18 |
| Företag | Position | Slut |
|---|---|---|
| OMEA THER | Finansdirektör/CFO | 2024-05-31 |
| ALDEYRA THERAPEUTICS, INC. | Finansdirektör/CFO | 2022-05-10 |
| BRISTOL-MYERS SQUIBB COMPANY | Företagsledare/Principal | 2018-07-01 |
| JPMORGAN CHASE & CO. | Företagsledare/Principal | 2005-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
JPMorgan Chase & Co.
JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services | Finance |
Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alkermes Plc
Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Omega Therapeutics, Inc.
Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån